FranΓ§aisπ See the interactive version (live chart) β
For Everpure, we replayed every analyst price target of the past 12 months and measured the real outcome: β% were profitable, average return β (0 calls). At 3 months: +8% average return (50% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
Not enough scored calls for a reliable ranking.
Is Everpure overvalued, and is it a good time to buy Everpure right now? If you're wondering, here's a recap to make up your own mind: Everpure's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Everpure | Sector median (Information Technology) |
|---|---|---|
| P/E | 135.9 | 39.4 |
| Forward P/E | 28.7 | 20.6 |
| Net margin | 6% | 16% |
π Everpure trades above its sector median (135.9 vs 39.4) β the market expects higher growth; watch out for disappointment.
π P/E, PEG, marginβ¦: see the glossary
The analyst consensus on Everpure (P) is "Buy" (27 bullish, 3 bearish calls over 12 months). This is not advice: historically, β% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $104 (+5% vs $99.24), ranging from $70.00 to $170 (14 analysts).
Over 1 year, β% of analyst targets on Everpure were profitable, for an average return of β (across 0 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $104 within 12 months, i.e. +5% vs the current price. The most bullish targets $170, the most cautious $70.00.
Note: analyst targets are 12-month (median $104, +5%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (β%), and the stock's past trajectory.
Its P/E is 135.9, forward P/E 28.7. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Everpure β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.